MedPath

Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans

Not Applicable
Conditions
Non-alcoholic Fatty Liver Disease NAFLD
Interventions
Diagnostic Test: 13C-α-Ketoisocaproic Acid Breath Test
Dietary Supplement: Ethanol
Dietary Supplement: Lipid Emulsion
Other: Normal Saline
Registration Number
NCT06559878
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

The goal of this clinical trial is to investigate in healthy volunteers the mechanisms by which ethanol and lipids, the two key risk factors of steatotic liver disease (SLD), affect liver mitochondrial metabolism.

The main question it aims to answer is:

• Does acute administration of ethanol and lipids increase hepatic mitochondrial reductive stress as determined by orally ingested stable isotope tracer 13C-alpha-ketoisocaproate and by plasma beta-hydroxybutyrate to acetoacetate ratio (b-OHB/AcAc) in humans?

Detailed Description

In this study we investigate the effects of ethanol and lipids on hepatic mitochondrial metabolism in healthy volunteers.

At first visit, an informed consent will be obtained, followed by assessment of inclusion/exclusion criteria. Participants fulfilling the criteria will be enrolled in the study. Body composition will be determined with bioelectrical impedance.

At second visit hepatic lipid content will be measured with magnetic resonance spectroscopy.

Participants will be given in random order on three separate visits (3-5):

* Intravenous infusion of ethanol and normal saline (breath alcohol content target and upper limit corresponding to 0.6 per mil in blood)

* Intravenous infusions of lipid emulsion, heparin and normal saline

* Intravenous infusion of normal saline

On study visits participant will drink a tracer dose of 13C-alpha-ketoisocaproate and L-Leucine. Breath samples are collected at different time points for determination of 13C enrichment of CO2. Furthermore "arterialized" blood samples are taken during study visits to obtain beta-hydroxybutyrate to acetoacetate ratios (b-OHB/AcAc) at different timepoints.

Whole-body oxidation of lipids, carbohydrates and protein will be determined using indirect calorimetry.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
The order of metabolic visits: 1.Lipid emulsion, 2.Normal saline, 3.Ethanol13C-α-Ketoisocaproic Acid Breath Test-
The order of metabolic visits: 1.Lipid emulsion, 2.Ethanol, 3.Normal salineEthanol-
The order of metabolic visits: 1. Normal saline, 2. Ethanol, 3. Lipid emulsionNormal Saline-
The order of metabolic visits: 1. Ethanol, 2. Lipid emulsion, 3. Normal salineNormal Saline-
The order of metabolic visits: 1. Normal saline, 2. Ethanol, 3. Lipid emulsion13C-α-Ketoisocaproic Acid Breath Test-
The order of metabolic visits: 1.Normal saline, 2.Lipid emulsion, 3.EthanolEthanol-
The order of metabolic visits: 1. Normal saline, 2. Ethanol, 3. Lipid emulsionEthanol-
The order of metabolic visits: 1.Normal saline, 2.Lipid emulsion, 3.Ethanol13C-α-Ketoisocaproic Acid Breath Test-
The order of metabolic visits: 1. Ethanol, 2. Normal saline, 3. Lipid emulsionLipid Emulsion-
The order of metabolic visits: 1. Ethanol, 2. Lipid emulsion, 3. Normal salineEthanol-
The order of metabolic visits: 1.Lipid emulsion, 2.Normal saline, 3.EthanolNormal Saline-
The order of metabolic visits: 1.Lipid emulsion, 2.Ethanol, 3.Normal salineNormal Saline-
The order of metabolic visits: 1. Ethanol, 2. Normal saline, 3. Lipid emulsion13C-α-Ketoisocaproic Acid Breath Test-
The order of metabolic visits: 1.Lipid emulsion, 2.Normal saline, 3.EthanolEthanol-
The order of metabolic visits: 1. Normal saline, 2. Ethanol, 3. Lipid emulsionLipid Emulsion-
The order of metabolic visits: 1.Normal saline, 2.Lipid emulsion, 3.EthanolLipid Emulsion-
The order of metabolic visits: 1.Normal saline, 2.Lipid emulsion, 3.EthanolNormal Saline-
The order of metabolic visits: 1.Lipid emulsion, 2.Normal saline, 3.EthanolLipid Emulsion-
The order of metabolic visits: 1.Lipid emulsion, 2.Ethanol, 3.Normal salineLipid Emulsion-
The order of metabolic visits: 1. Ethanol, 2. Normal saline, 3. Lipid emulsionNormal Saline-
The order of metabolic visits: 1.Lipid emulsion, 2.Ethanol, 3.Normal saline13C-α-Ketoisocaproic Acid Breath Test-
The order of metabolic visits: 1. Ethanol, 2. Normal saline, 3. Lipid emulsionEthanol-
The order of metabolic visits: 1. Ethanol, 2. Lipid emulsion, 3. Normal saline13C-α-Ketoisocaproic Acid Breath Test-
The order of metabolic visits: 1. Ethanol, 2. Lipid emulsion, 3. Normal salineLipid Emulsion-
Primary Outcome Measures
NameTimeMethod
Change in arterialized plasma b-OHB to AcAc ratioFrom baseline to the end of treatment at 240 minutes

Arterialized plasma b-OHB and AcAc concentrations

Breath 13CO2 enrichment after ingesting 13C-alpha-ketoisocaproateFrom baseline to the end of treatment at 330 minutes.

Measured as area under the curve

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Helsinki Central University Hospital

🇫🇮

Helsinki, Uusimaa, Finland

© Copyright 2025. All Rights Reserved by MedPath